Provided by Tiger Trade Technology Pte. Ltd.

Aspire Biopharma Holdings Inc.

7.89
-0.0800-1.00%
Volume:40.23K
Turnover:322.74K
Market Cap:11.07M
PE:-0.92
High:8.17
Open:7.90
Low:7.89
Close:7.97
52wk High:714.00
52wk Low:3.31
Shares:1.40M
Float Shares:1.11M
Volume Ratio:1.99
T/O Rate:3.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5310
EPS(LYR):-491.2689
ROE:-1032.14%
ROA:60.58%
PB:0.94
PE(LYR):-0.02

Loading ...

Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 23, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 20, 2026

Major Issues Report

Form 8-K - Current report
Apr 17, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 16, 2026

Major Issues Report

Form 8-K - Current report
Apr 16, 2026

Major Issues Report

Form 8-K - Current report
Apr 16, 2026

Major Issues Report

Form 8-K - Current report